• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dopamine D-1 receptors in the parkinsonian brain.

作者信息

Rinne J O, Rinne J K, Laakso K, Lönnberg P, Rinne U K

出版信息

Brain Res. 1985 Dec 16;359(1-2):306-10. doi: 10.1016/0006-8993(85)91441-6.

DOI:10.1016/0006-8993(85)91441-6
PMID:2934111
Abstract

Dopamine D-1 receptors were analyzed in the caudate nucleus, putamen, pallidum, substantia nigra and nucleus accumbens in 20 patients with Parkinson's disease and in 18 age-matched controls by the binding of [3H]flupenthixol. The binding was decreased in the substantia nigra in those parkinsonian patients who were not treated with levodopa. A significantly increased number of D-1 receptors was found in the putamen of patients with Parkinson's disease, especially in those who were treated with levodopa. The increased binding of [3H]flupenthixol was most prominent in those six parkinsonian patients who still had therapeutic response to levodopa. In addition, orofacial dyskinesias were seen in three of these patients. The results of this study indicate that there may be denervation supersensitivity of striatal neurons and also a loss of striatonigral neurons in Parkinson's disease.

摘要

相似文献

1
Dopamine D-1 receptors in the parkinsonian brain.
Brain Res. 1985 Dec 16;359(1-2):306-10. doi: 10.1016/0006-8993(85)91441-6.
2
Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neuron system of human brain.人脑黑质-中脑多巴胺能神经元系统中多巴胺D2受体的区域分布。
J Neurol Sci. 1985 Nov;71(1):119-27. doi: 10.1016/0022-510x(85)90041-3.
3
Parkinson's disease as a model for changes in dopamine receptor dynamics with aging.帕金森病作为多巴胺受体动力学随衰老变化的模型。
Gerontology. 1982;28 Suppl 1:35-52. doi: 10.1159/000212572.
4
Substance P immunoreactivity in the post-mortem parkinsonian brain.帕金森病患者死后大脑中的P物质免疫反应性。
Brain Res. 1984 Jun 11;303(1):113-6. doi: 10.1016/0006-8993(84)90217-8.
5
Dopamine D2 receptor density remains constant in treated Parkinson's disease.在接受治疗的帕金森病患者中,多巴胺D2受体密度保持不变。
Ann Neurol. 1986 May;19(5):487-92. doi: 10.1002/ana.410190510.
6
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.帕金森病和核上性麻痹中[3H]司哌罗宁结合、多巴胺及高香草酸浓度
Eur J Pharmacol. 1984 Mar 23;99(2-3):167-75. doi: 10.1016/0014-2999(84)90238-3.
7
Brain enkephalin receptors in Parkinson's disease.帕金森病中的脑内脑啡肽受体
J Neural Transm Suppl. 1983;19:163-71.
8
Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.用定量放射自显影法测定猫基底神经节中多巴胺D1和D2受体的分布。
J Comp Neurol. 1988 Feb 1;268(1):131-45. doi: 10.1002/cne.902680113.
9
[3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
Brain Res. 1986 Jul 2;377(1):186-9. doi: 10.1016/0006-8993(86)91207-2.
10
Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's disease.
Brain Res Mol Brain Res. 2001 Mar 5;87(2):271-9. doi: 10.1016/s0169-328x(01)00022-5.

引用本文的文献

1
Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease.多巴胺缺失在帕金森病病理生理学中对纹状体以外基底神经节核团的影响。
Front Aging Neurosci. 2014 May 13;6:87. doi: 10.3389/fnagi.2014.00087. eCollection 2014.
2
Motor fluctuations and dyskinesias in advanced/end stage Parkinson's disease: a study from a population of brain donors.晚期帕金森病的运动波动和异动症:一项来自脑捐赠者群体的研究
J Neural Transm (Vienna). 2007 Mar;114(3):341-5. doi: 10.1007/s00702-006-0603-6. Epub 2006 Dec 7.
3
Psychotic symptoms in Parkinson's disease. From description to etiology.
帕金森病中的精神症状。从描述到病因
J Neurol. 2005 Jul;252(7):753-64. doi: 10.1007/s00415-005-0918-5.
4
Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study.帕金森病和纹状体黑质变性中的多巴胺D1受体:一项正电子发射断层扫描研究。
J Neurol Neurosurg Psychiatry. 1993 May;56(5):467-72. doi: 10.1136/jnnp.56.5.467.
5
Chronic administration of a selective dopamine D-2 agonist: factors determining behavioral tolerance and sensitization.选择性多巴胺 D-2 激动剂的长期给药:决定行为耐受性和敏化的因素。
Psychopharmacology (Berl). 1988;95(4):534-9. doi: 10.1007/BF00172969.